Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Futura Medical's gross profit for the
six
months ended in Dec. 2025 was $1.34 Mil. Futura Medical's gross profit for the trailing twelve months (TTM) ended in Dec. 2025 was $1.67 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Futura Medical's gross profit for the
six
months ended in Dec. 2025 was $1.34 Mil. Futura Medical's Revenue for the
six
months ended in Dec. 2025 was $0.93 Mil. Therefore, Futura Medical's Gross Margin % for the quarter that ended in Dec. 2025 was 143.24%.
Futura Medical had a gross margin of 143.24% for the quarter that ended in Dec. 2025 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Futura Medical was 73.07%. The lowest was 57.21%. And the median was 69.57%.
Futura Medical (OTCPK:FAMDF) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Futura Medical had a gross margin of 143.24% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Futura Medical Gross Profit Related Terms
Futura Medical Gross Profit Historical Data
* Premium members only.
The historical data trend for Futura Medical's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FAMDF vs VRTX, REGN, ALNY: Gross Profit Comparison
For the Biotechnology subindustry, Futura Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Futura Medical Gross Profit vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Futura Medical's Gross Profit distribution charts can be found below:
* The bar in red indicates where Futura Medical's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.67 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Futura Medical (FAMDF) has a Gross Profit of $1.67 Mil as of Dec. 2025. Gross Profit equals net sales less total cost of goods sold. View historical data on Futura Medical and its competitors.
Is Futura Medical's Gross Profit too high?
Futura Medical's current Gross Profit is $1.67 Mil.
How does Futura Medical's Gross Profit compare to VRTX and REGN?
Futura Medical's Gross Profit of $1.67 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Biotechnology company?
A good Gross Profit depends on the Biotechnology industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Futura Medical and its competitors. Futura Medical's current Gross Profit is $1.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Futura Medical stock overvalued right now?
Based on GuruFocus' analysis, Futura Medical (FAMDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.08, compared to a current price of $0.00 — trading 95% below its estimated fair value. The current Gross Profit is $1.67 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Futura Medical (FAMDF), the current Gross Profit is $1.67 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FAMDF has been successfully added to your 
